Vilas-Boas, E. A., Karabacz, N., Marsiglio-Librais, G. N., Valle, M. M. R., Nalbach, L., Ampofo, E., . . . Roma, L. P. (2020). Chronic activation of GPR40 does not negatively impact upon BRIN-BD11 pancreatic β-cell physiology and function. Pharmacol Rep.

Vilas-Boas, Eloisa Aparecida, Noémie Karabacz, Gabriela Nunes Marsiglio-Librais, Maíra Melo Rezende Valle, Lisa Nalbach, Emmanuel Ampofo, Bruce Morgan, Angelo Rafael Carpinelli, و Leticia Prates Roma. "Chronic Activation of GPR40 Does Not Negatively Impact Upon BRIN-BD11 Pancreatic β-cell Physiology and Function." Pharmacol Rep 2020.

Vilas-Boas, Eloisa Aparecida, et al. "Chronic Activation of GPR40 Does Not Negatively Impact Upon BRIN-BD11 Pancreatic β-cell Physiology and Function." Pharmacol Rep 2020.